Since the start of their development in the 1970s, biologic therapies have transformed the lives of millions of patients with serious illnesses. Today, biologic agents continue to outpace small molecule medicines in terms of market growth. The latest Visiongain study predicts the world market for biologics will reach US$270bn in 2019, with strong revenue expansion from 2015 to 2025.1
A whole life science industry has grown up around their development to provide the building blocks, production and analytical equipment and services required for their manufacture. Process technology has evolved rapidly from laboratory to production scale, and a number of major suppliers have grown alongside it.
EMD Millipore is one of those companies. Founded in 1954, the Millipore Filter Co started as a filtration company, pioneering the use of membrane technology. Since then the company has increased its product range and acquired new businesses. In 2010, the Millipore Corporation was acquired by Merck KGaA, Darmstadt, Germany and operates under the brandname EMD Millipore in the US and Canada (and is known as Merck Millipore in the rest of the world).
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.